Short- Versus Long-course Therapy in Gram-negative Bacilli Bloodstream Infections
Overview
Microbiology
Authors
Affiliations
Bacteremia due to gram-negative bacilli (GNB) is one of the most frequent causes of admission and prolongation of hospital stay. Nevertheless, optimal duration of antibiotic treatment is not clearly established. We designed an observational, prospective study of a cohort of adult patients with uncomplicated GNB bacteremia. They were classified according to the duration of treatment in short (7-10 days) or long (> 10 days) course. Mortality and bacteremia recurrence rate were evaluated, and propensity score for receiving short-course treatment was calculated. A total of 395 patients met eligibility criteria including 232 and 163 who received long- and short-course therapy, respectively. Median age was 71 years, 215 (54.4% male) and 51% had a urinary source. Thirty-day mortality was 12%. In multivariate analysis by logistic regression stratified according to propensity score quartile for receiving short-course therapy showed no association of duration of treatment with 30-day mortality or 90-day recurrence rate. Based on the results observed in our cohort, short-course therapy could be as safe and effective as longer courses.
Su L, Cao Y, Liu Y, Zhang J, Zhang G Medicine (Baltimore). 2024; 103(45):e40411.
PMID: 39533568 PMC: 11557057. DOI: 10.1097/MD.0000000000040411.
Corona A, De Santis V, Agarossi A, Prete A, Cattaneo D, Tomasini G Antibiotics (Basel). 2023; 12(8).
PMID: 37627683 PMC: 10451333. DOI: 10.3390/antibiotics12081262.
Antibiotic stewardship in the ICU: time to shift into overdrive.
Mokrani D, Chommeloux J, De Chambrun M, Hekimian G, Luyt C Ann Intensive Care. 2023; 13(1):39.
PMID: 37148398 PMC: 10163585. DOI: 10.1186/s13613-023-01134-9.
Turjeman A, von Dach E, Molina J, Franceschini E, Koppel F, Yelin D EClinicalMedicine. 2022; 55:101750.
PMID: 36483269 PMC: 9722443. DOI: 10.1016/j.eclinm.2022.101750.
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.
Babich T, Naucler P, Valik J, Giske C, Benito N, Cardona R Infect Dis Ther. 2022; 11(4):1505-1519.
PMID: 35612693 PMC: 9334465. DOI: 10.1007/s40121-022-00657-1.